TABLE 1.
Patient Characteristics (n = 19)
| Characteristic | Summary |
|---|---|
| Age, median (range), y | 49 (30–80) |
| Sex, No. (%) | |
| Female | 8 (42) |
| Male | 11 (58) |
| Performance status, No. (%) | |
| 0 | 9 (47) |
| 1 | 8 (42) |
| 2 | 2 (11) |
| Ethnicity, No. (%) | |
| Hispanic | 0 (0) |
| Not Hispanic | 19 (100) |
| Race, No. (%) | |
| White | 18 (95) |
| Unknown race | 1 (5) |
| Primary site, No. (%) | |
| Cecum | 1 (5) |
| Cervix | 2 (11) |
| Colon | 1 (5) |
| Esophagus | 1 (5) |
| GE junction | 2 (11) |
| Larynx | 1 (5) |
| Lunga | 1 (5) |
| Nasal cavity | 1 (5) |
| Poorly differentiated pancreas | 2 (11) |
| Rectum | 2 (11) |
| Unknown primary | 4 (21) |
| Vulva | 1 (5) |
| Ki-67, median (range), % | 80 (20–99) |
| Microsatellite instability status, No. (%) | |
| MSS | 19 (100) |
| Prior lines of therapy, median (range) | 1 (0–3) |
| Differentiation, No. (%) | |
| Well differentiated | 1 (5) |
| Moderately differentiated | 1 (5) |
| Poorly differentiated | 11 (58) |
| Unknown | 6 (32) |
Abbreviations: GE, gastroesophageal; MSS, microsatellite stable.
a
Atypical lung neuroendocrine tumor (high-grade).